 |
 |
The researchers are still debating the results of this trial . There's a good "News in Context" discussion and analysis about the Adagio study on the Fox Foundation site at: http://www.michaeljfox.org/research_viewpoints_newsInContext_article.cfm?ID=15 September 23, 2009 From Teva's ADAGIO Trial: Inconclusive Results, but Possible Disease-modifying Effect, for Azilect (Rasagiline) The bottom line is : More research is needed. excerpt: "MJFF: So, at the end of the day, what should be the takeaway, if any? It sounds like each patient simply has to weigh the costs and benefits, depending on the state of his or her own disease and disability, and work closely with his or her doctor. There are no simple answers, as usual. KK (Karl Kieburtz),: Is there a clear, urgent message for patients in terms of treating their Parkinson’s disease? No. There’s no quick answer. There is no definitive therapeutic recommendation that arises for people with Parkinson’s disease. My expectation is that many people with early otherwise untreated PD will choose to go on this medication, after talking with their doctors and considering their other treatment options. " ---------- Original Message ---------- From: mschild <[log in to unmask]> To: [log in to unmask] Subject: Re: Azilect slows progression of PD Date: Thu, 8 Apr 2010 08:42:41 +0200 > http://www.lumra.com/info-blog/azilect-slows-progression-of-parkinsons-dise >ase.html dates from 2008 and emanates from the companies that sell it maryse ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn